Law360, New York (April 16, 2009) -- A month after the U.S. Supreme Court rejected Wyeth Pharmaceutical Inc.'s federal preemption argument, a Texas appeals court has dealt another blow to the drugmaker, reversing Wyeth's victory in a case over the company's hormone replacement drug Prempro.
Ruling that federal law did not trump a state law failure-to-warn claim, the Court of Appeals of Texas in Houston on Tuesday revived Susan Brockert's product liability action against Wyeth...
